In previous human in vivo studies, most robust increases in TSPO-binding have been found in Alzheimer’s dementia in comparison to controls [20–22, 49], but also in Aβ-positive MCI [4, 24, 25] and Aβ-positive controls [7, 26]. This evidence concerns the gene TSPO and Alzheimer disease.